Skip to main content
Top
Published in: Rheumatology International 2/2021

01-02-2021 | Systemic Lupus Erythematosus | Case Based Review

Systemic lupus erythematosus complicated with Castleman disease: a case-based review

Authors: Fatma Gül Demirkan, Sümeyra Doğan, Ayşe Kalyoncu Uçar, Hafize Emine Sönmez, Nuray Aktay Ayaz

Published in: Rheumatology International | Issue 2/2021

Login to get access

Abstract

Systemic lupus erythematosus (SLE) is a complex, chronic, multi-systemic autoimmune disease, characterized by miscellaneous clinical findings. Castleman disease (CD) is a rare lymphoproliferative disorder that may present with systemic symptoms. Herein, a SLE case complicated with CD is reported by comparing her clinical findings with previously reported patients. We reviewed the literature regarding cases of “Castleman disease” and “Systemic lupus erythematosus” by searching medical journal databases in MEDLINE, EMBASE, Scopus, and Web of Science. A case of a 16-year-old girl with SLE who had intraabdominal lymphadenopathy detected both by ultrasonography and abdominal magnetic resonance imaging is presented. The excision of the lymph node was performed by pediatric surgeons. Histopathological examination was compatible with CD. Hydroxychloroquine and steroid treatments were started after the operation. She achieved remission in 3 months. In the literature research, we found 10 articles describing 17 patients. To our best of knowledge, the presented case was the third pediatric case in the literature with SLE and coexistent CD. This case report and literature review suggests that CD should be considered while evaluating and following patients with autoimmune diseases.
Literature
1.
go back to reference Petri M, Orbai AM, Alarcon GS et al (2012) Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64:2677–2686CrossRef Petri M, Orbai AM, Alarcon GS et al (2012) Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64:2677–2686CrossRef
3.
go back to reference Scott GD, Kumar J, Oak JS, Boyd SD, Raess PW, Gratzinger DA (2020) Histology-independent signature distinguishes Kikuchi-Fujimoto disease/systemic lupus erythematosus-associated lymphadenitis from benign and malignant lymphadenopathies. Am J Clin Pathol 154:215–224CrossRef Scott GD, Kumar J, Oak JS, Boyd SD, Raess PW, Gratzinger DA (2020) Histology-independent signature distinguishes Kikuchi-Fujimoto disease/systemic lupus erythematosus-associated lymphadenitis from benign and malignant lymphadenopathies. Am J Clin Pathol 154:215–224CrossRef
4.
go back to reference Van de Voorde K, De Raeve H, De Block CE, Van Regenmortel N, Van Offel JF, De Clerck LS, Stevens WJ (2004) Atypical systemic lupus erythematosus or Castleman’s disease. Acta Clin Belg 59:161–164CrossRef Van de Voorde K, De Raeve H, De Block CE, Van Regenmortel N, Van Offel JF, De Clerck LS, Stevens WJ (2004) Atypical systemic lupus erythematosus or Castleman’s disease. Acta Clin Belg 59:161–164CrossRef
5.
go back to reference De Marchi G, De Vita S, Fabris M, Scott CA, Ferraccioli G (2004) Systemic connective tissue disease complicated by Castleman’s disease: report of a case and review of the literature. Haematologica 89:ECR03PubMed De Marchi G, De Vita S, Fabris M, Scott CA, Ferraccioli G (2004) Systemic connective tissue disease complicated by Castleman’s disease: report of a case and review of the literature. Haematologica 89:ECR03PubMed
6.
go back to reference Xia JY, Chen XY, Xu F, Yang Y, Wang HY, Xue J (2012) A case report of systemic lupus erythematosus combined with Castleman’s disease and literature review. Rheumatol Int 32:2189–2193CrossRef Xia JY, Chen XY, Xu F, Yang Y, Wang HY, Xue J (2012) A case report of systemic lupus erythematosus combined with Castleman’s disease and literature review. Rheumatol Int 32:2189–2193CrossRef
7.
go back to reference Kojima M, Nakamura S, Morishita Y et al (2000) Reactive follicular hyperplasia in the lymph node lesions from systemic lupus erythematosus patients: a clinicopathological and immunohistological study of 21 cases. Pathol Int 50:304–312CrossRef Kojima M, Nakamura S, Morishita Y et al (2000) Reactive follicular hyperplasia in the lymph node lesions from systemic lupus erythematosus patients: a clinicopathological and immunohistological study of 21 cases. Pathol Int 50:304–312CrossRef
8.
go back to reference Keller AR, Hochholzer L, Castleman B (1972) Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 29:670–683CrossRef Keller AR, Hochholzer L, Castleman B (1972) Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 29:670–683CrossRef
9.
go back to reference Shariatpanahi S, Pourfarzam S, Gheini M (2016) Association of macrophage activating syndrome with Castleman’s syndrome in systemic lupus erythematosus. Iran J Pathol 11:265–271PubMedPubMedCentral Shariatpanahi S, Pourfarzam S, Gheini M (2016) Association of macrophage activating syndrome with Castleman’s syndrome in systemic lupus erythematosus. Iran J Pathol 11:265–271PubMedPubMedCentral
10.
go back to reference Zhang L, Jiao L, Wang SJ (2015) Successful Treatment with rituximab in a patient with Castleman’s Disease complicated by systemic lupus erythematosus and severe autoimmune thrombocytopenia. Chin Med J 128:2551–2552CrossRef Zhang L, Jiao L, Wang SJ (2015) Successful Treatment with rituximab in a patient with Castleman’s Disease complicated by systemic lupus erythematosus and severe autoimmune thrombocytopenia. Chin Med J 128:2551–2552CrossRef
11.
go back to reference Oyaert M, Boone E, De Ceuninck L, Moreau E, Van Dorpe J, Vanpoucke H, Deeren D (2014) Clonal multicentric Castleman’s disease with increased free Kappa light chains in a patient with systemic lupus erythematosus. Ann Hematol 93:1255–1257PubMed Oyaert M, Boone E, De Ceuninck L, Moreau E, Van Dorpe J, Vanpoucke H, Deeren D (2014) Clonal multicentric Castleman’s disease with increased free Kappa light chains in a patient with systemic lupus erythematosus. Ann Hematol 93:1255–1257PubMed
12.
go back to reference Kojima M, Motoori T, Asano S, Nakamura S (2007) Histological diversity of reactive and atypical proliferative lymph node lesions in systemic lupus erythematosus patients. Pathol Res Pract 203:423–431CrossRef Kojima M, Motoori T, Asano S, Nakamura S (2007) Histological diversity of reactive and atypical proliferative lymph node lesions in systemic lupus erythematosus patients. Pathol Res Pract 203:423–431CrossRef
13.
go back to reference Simko R, Nagy K, Lombay B, Kiss A, Minik K, Lukacs VH, Vamosi I (2000) Multicentric Castleman disease and systemic lupus erythematosus phenotype in a boy with Klinefelter syndrome: long-term disease stabilization with interferon therapy. J Pediatr Hematol Oncol 22:180–183CrossRef Simko R, Nagy K, Lombay B, Kiss A, Minik K, Lukacs VH, Vamosi I (2000) Multicentric Castleman disease and systemic lupus erythematosus phenotype in a boy with Klinefelter syndrome: long-term disease stabilization with interferon therapy. J Pediatr Hematol Oncol 22:180–183CrossRef
14.
go back to reference Suwannaroj S, Elkins SL, McMurray RW (1999) Systemic lupus erythematosus and Castleman’s disease. J Rheumatol 26:1400–1403PubMed Suwannaroj S, Elkins SL, McMurray RW (1999) Systemic lupus erythematosus and Castleman’s disease. J Rheumatol 26:1400–1403PubMed
15.
go back to reference Kojima M, Nakamura S, Itoh H, Yoshida K, Asano S, Yamane N, Komatsumoto S, Ban S, Joshita T, Suchi T (1997) Systemic lupus erythematosus (SLE) lymphadenopathy presenting with histopathologic features of Castleman’ disease: a clinicopathologic study of five cases. Pathol Res Pract 193:565–571CrossRef Kojima M, Nakamura S, Itoh H, Yoshida K, Asano S, Yamane N, Komatsumoto S, Ban S, Joshita T, Suchi T (1997) Systemic lupus erythematosus (SLE) lymphadenopathy presenting with histopathologic features of Castleman’ disease: a clinicopathologic study of five cases. Pathol Res Pract 193:565–571CrossRef
16.
go back to reference Frizzera G, Peterson BA, Bayrd ED, Goldman A (1985) A systemic lymphoproliferative disorder with morphologic features of Castleman’s disease: clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol 3:1202–1216CrossRef Frizzera G, Peterson BA, Bayrd ED, Goldman A (1985) A systemic lymphoproliferative disorder with morphologic features of Castleman’s disease: clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol 3:1202–1216CrossRef
17.
go back to reference Ying Hu XZ (2013) Castleman’s disease combined with the development of systemic lupus erythematosus. Turk J Rheumatol 28:143–144CrossRef Ying Hu XZ (2013) Castleman’s disease combined with the development of systemic lupus erythematosus. Turk J Rheumatol 28:143–144CrossRef
Metadata
Title
Systemic lupus erythematosus complicated with Castleman disease: a case-based review
Authors
Fatma Gül Demirkan
Sümeyra Doğan
Ayşe Kalyoncu Uçar
Hafize Emine Sönmez
Nuray Aktay Ayaz
Publication date
01-02-2021
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 2/2021
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-020-04684-4

Other articles of this Issue 2/2021

Rheumatology International 2/2021 Go to the issue